*Doses are commonly-reported figures from public sources, not a recommendation. Educational only.
| Year | Title / venue | Source |
|---|---|---|
| 2025 | Acetyl Hexapeptide-8 in Cosmeceuticals-A Review of Skin Permeability and Efficacy International journal of molecular sciences · preclinical | PMID 40565185 |
| 2025 | BAK and ARG Have Moisturizing, Anti-Inflammatory, Antioxidant, and Antioxidant Bioactivities, in the Zebrafish Model Journal of cosmetic dermatology · preclinical | PMID 40176351 |
| 2024 | Cosmeceuticals in photoaging: A review Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · preclinical | PMID 39233460 |
| 2024 | Public Interest in Acetyl Hexapeptide-8: Longitudinal Analysis JMIR dermatology · preclinical | PMID 38376906 |
| 2023 | Polydioxanone Bioactive Sutures-Acetyl Hexapeptide-8 (Argireline): An Intelligent System for Controlled Release in Facial Harmonization Journal of cutaneous and aesthetic surgery · preclinical | PMID 38314369 |
| 2021 | Argireline: Needle-Free Botox as Analytical Challenge Chemistry & biodiversity · preclinical | PMID 33482052 |
| 2013 | The anti wrinkle efficacy of synthetic hexapeptide (Argireline) in Chinese Subjects Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology · preclinical | PMID 23607739 |
| 2002 | A synthetic hexapeptide (Argireline) with antiwrinkle activity International journal of cosmetic science · preclinical | PMID 18498523 |
Argireline (Argireline (Acetyl Hexapeptide-3 / -8)). Topical cosmetic hexapeptide that mimics the N-terminal of SNAP-25, modulating SNARE-complex assembly to soften dynamic expression wrinkles ('topical Botox-like' marketing claim, far weaker mechanism).
Commonly discussed uses: topical anti-wrinkle cosmetics (forehead/eye expression lines). There is some human research, though it may be limited, early-phase, or for a narrow indication. Note: most uses are not approved indications.
Mechanism: Topical cosmetic hexapeptide that mimics the N-terminal of SNAP-25, modulating SNARE-complex assembly to soften dynamic expression wrinkles ('topical Botox-like' marketing claim, far weaker mechanism).
Reported considerations: topical: rare irritation; effect modest vs marketing claims. There is some human research, though it may be limited, early-phase, or for a narrow indication. Legal topical cosmetic ingredient in AU/US/UK. Not an injectable/therapeutic. This is not a safety endorsement; safety data for unapproved compounds is incomplete.
Commonly cited ranges (educational reference, not a recommendation): low topical 5%, typical topical 5-10%, high topical 10%. Administration: topical. Half-life: topical local action.
Australian status: Permitted cosmetic ingredient. Legal topical cosmetic ingredient in AU/US/UK. Not an injectable/therapeutic. General regulatory context: most active peptides are Schedule 4 and require a prescription; import via the Personal Importation Scheme requires a valid Australian prescription for prescription-only goods.
Reconstitution/storage reference: pre-formulated cosmetic (no reconstitution); storage: room temp per product.
Commonly discussed combinations (anecdotal for unapproved compounds): topical with Matrixyl / SNAP-8 (cosmetic). Stacking increases interaction/safety uncertainty.